dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Jones, Robin L. |
dc.contributor.author | Valverde Morales, Claudia Maria |
dc.contributor.author | Benson, Charlotte |
dc.contributor.author | Blay, Jean-Yves |
dc.contributor.author | Gelderblom, Hans |
dc.contributor.author | George, Suzanne |
dc.date.accessioned | 2021-10-22T06:27:23Z |
dc.date.available | 2021-10-22T06:27:23Z |
dc.date.issued | 2020-04-14 |
dc.identifier.citation | Gelderblom H, Jones RL, George S, Valverde Morales C, Benson C, Blay JY, et al. Imatinib in combination with phosphoinositol kinase inhibitor buparlisib in patients with gastrointestinal stromal tumour who failed prior therapy with imatinib and sunitinib: a Phase 1b, multicentre study. Br J Cancer. 2020 Apr 14;122(8):1158–65. |
dc.identifier.issn | 1532-1827 |
dc.identifier.uri | https://hdl.handle.net/11351/6439 |
dc.description | Càncer gàstric; Imatinib i sunitinib; Resistència al tractament |
dc.description.sponsorship | The study was funded by Novartis Pharma AG, Basel, Switzerland. |
dc.language.iso | eng |
dc.publisher | Springer Nature |
dc.relation.ispartofseries | British Journal of Cancer;122(8) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Tub digestiu - Càncer - Quimioteràpia |
dc.subject.mesh | Gastrointestinal Stromal Tumors |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols |
dc.subject.mesh | /therapeutic use |
dc.title | Imatinib in combination with phosphoinositol kinase inhibitor buparlisib in patients with gastrointestinal stromal tumour who failed prior therapy with imatinib and sunitinib: a Phase 1b, multicentre study |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41416-020-0769-y |
dc.subject.decs | tumores del estroma gastrointestinal |
dc.subject.decs | protocolos de quimioterapia antineoplásica combinada |
dc.subject.decs | /uso terapéutico |
dc.relation.publishversion | https://doi.org/10.1038/s41416-020-0769-y |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Gelderblom H] Leiden University Medical Center, Leiden, The Netherlands. [Jones RL] The Royal Marsden Hospital and Institute of Cancer Research, London, UK. [George S] Dana-Farber Cancer Institute Boston, Boston, MA, USA. [Valverde Morales C] Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Benson C] The Royal Marsden Hospital, London, UK. [Blay JY] Centre Léon Bérard, Lyon, France. Unicancer, Paris, France |
dc.identifier.pmid | 32147671 |
dc.identifier.wos | 000518499500001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |